Mode of action of antibacterial agents.
D000595:Amino Acid Sequence / Q000187:drug effects; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D001426:Bacterial Proteins / Q000096:biosynthesis; D002462:Cell Membrane / Q000187:drug effects; D002473:Cell Wall / Q000187:drug effects; D004261:DNA Replication / Q000187:drug effects; D004352:Drug Resistance, Microbial; D005492:Folic Acid / Q000096:biosynthesis; D005493:Folic Acid Antagonists / Q000494:pharmacology; D005672:Fusidic Acid / Q000494:pharmacology; D008855:Microscopy, Electron, Scanning; D009268:Nalidixic Acid / Q000494:pharmacology; D011511:Proteus / Q000187:drug effects; D011743:Pyrimidines / Q000494:pharmacology; D012270:Ribosomes / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013449:Sulfonamides / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D013449:Sulfonamides; D009268:Nalidixic Acid; D005672:Fusidic Acid; D005492:Folic Acid